Concepedia

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Bo Yu, Chenze Li, Peng Chen, Ning Zhou, Luyun Wang, Jia Li, Hualiang Jiang, Dao Wen Wang

Science China Life Sciences · 2020 · 176 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

, , +10

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

, , +10

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

, , +12

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang et al. · Clinical Infectious Diseases · 2020 · 2.8K citations · Full text

, , +17

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang, Zhao Wu, Jiawen Li et al. · International Journal of Antimicrobial Agents · 2020 · 1.8K citations · Full text

, , +14